Sonnet Biotherapeutics Holdings Inc
Change company Symbol lookup
Select an option...
SONN Sonnet Biotherapeutics Holdings Inc
RIOCF RioCan Real Estate Investment Trust
OMP Oasis Midstream Partners LP
GMED Globus Medical Inc
TSN Tyson Foods Inc
VOO Vanguard S&P 500 ETF
PAYX Paychex Inc
VTNR Vertex Energy Inc
AGAUF Arizona Gold Corp
JWN Nordstrom Inc
Go

Company profile

Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Premarket

Last Trade
Delayed
$2.02
-0.05 (-2.42%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.07
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
1,458

10-day average volume:
1,781,935
1,458

Earnings information for SONN is not available.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.